CANCER MARS SHOT FIGHTING CANCER TOGETHER
Live / Applied — Opposition pending (as of 10 Jul 2024)
What this means for you
Not registered yet, but its 22 Dec 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97728483
- Mark type
- Design + words
- Filed
- 22 Dec 2022
- Published for opposition
- 12 Mar 2024
- Attorney of record
- ROBERT DEVIN RICCI
Goods and services
- Class 042 — Scientific and technological services: Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; conducting scientific research and scientific research in the nature of conducting clinical trials in the field of oncology and cancer research for others; Providing a website featuring educational information in the field of clinical research; Medical and scientific research, namely, conducting clinical trials for others; Providing medical testing services and information in the field of cancer research and disease classification; technical research and consulting in the field of pharmaceutical studies; Pharmaceutical research services; Pharmaceutical research and development; testing of pharmaceuticals; Biotechnology research; Medical research; DNA analysis services for scientific research purposes; Medical and scientific research in the field of molecular profiling and biomarker discovery in cancer patients; Medical and scientific research in the field of cancer treatment; Providing medical research information in the nature of medical research data pertaining to cancer and its treatment; consulting services for others in the field of project Management of clinical and translational trials in the field of cancer treatment for others in the nature of conducting clinical trials for others; Providing medical and scientific research in formation from clinical trials in the nature of research data pertaining to cancer; consulting services for others in the field of design, planning and implementation of clinical trials, specifically thedevelopment and validation of clinical trials and testsper formed during clinical trials; testing, analysis and evaluation of the clinical trials and tests of others to determine conformity with certification standards; Design,research, development and testing servicesin the field of pharmaceuticals, biobanking, and cancer research for medical and scientific purposes; Preclinical scientific and medical research services in the field of biospecimens collections; Research in the field of artificial intelligence for medical and scientific research purposes
Owner
- Audubon Health Group, LLC, Houston, TX, US
- Audubon Health Group, LLC, Houston, TX, US
Prosecution history
- 10 Jul 2024 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 10 Jul 2024 — OPPOSITION INSTITUTED NO. 999999
- 10 Apr 2024 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 12 Mar 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 Mar 2024 — PUBLISHED FOR OPPOSITION
- 21 Feb 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 21 Feb 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 05 Feb 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 05 Feb 2024 — EXAMINER'S AMENDMENT ENTERED
- 05 Feb 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 05 Feb 2024 — EXAMINERS AMENDMENT E-MAILED
- 05 Feb 2024 — EXAMINERS AMENDMENT -WRITTEN
- 08 Jan 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 08 Jan 2024 — NON-FINAL ACTION E-MAILED
- 08 Jan 2024 — NON-FINAL ACTION WRITTEN